Your browser doesn't support javascript.
loading
Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
Shin, Hyemi; Sa, Jason K; Bae, Joon Seol; Koo, Harim; Jin, Seonwhee; Cho, Hee Jin; Choi, Seung Won; Kyoung, Jong Min; Kim, Ja Yeon; Seo, Yun Jee; Joung, Je-Gun; Kim, Nayoung K D; Son, Dae-Soon; Chung, Jongsuk; Lee, Taeseob; Kong, Doo-Sik; Choi, Jung Won; Seol, Ho Jun; Lee, Jung-Il; Suh, Yeon-Lim; Park, Woong-Yang; Nam, Do-Hyun.
Afiliación
  • Shin H; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Sa JK; Deparment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • Bae JS; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Koo H; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
  • Jin S; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Cho HJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Choi SW; Deparment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • Kyoung JM; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Kim JY; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
  • Seo YJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Joung JG; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
  • Kim NKD; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Son DS; Deparment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • Chung J; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Lee T; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
  • Kong DS; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Choi JW; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
  • Seol HJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Lee JI; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
  • Suh YL; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Park WY; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Nam DH; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Cancer Res Treat ; 52(1): 41-50, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31096737
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Pruebas Genéticas / Secuenciación de Nucleótidos de Alto Rendimiento / Glioma / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Pruebas Genéticas / Secuenciación de Nucleótidos de Alto Rendimiento / Glioma / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article